In a loss-of-function assay, silencing ALOX5 in the 786-O and A498 ccRCC cell lines impaired their ability to proliferate, migrate, and engage in invasive activity in vitro and in vivo. This evidence concerns the gene ALOX5 and nonpapillary renal cell carcinoma.